Pfizer

Eli Lilly Broadens Diabetes Offer

Big Drugmakers Think Small with Nanomedicine Deals

Strong Pet Product Sales Help Zoetis Top Estimates

Pfizer Q1 Results Fall Short

Merck, Pfizer to Jointly Develop Diabetes Drug

AbbVie Delivers on Scorching Humira Drug Sales Growth

Optimer Shares Rise After Report Names Glaxo, Cubist as Potential Buyers

Novartis Loses Landmark India Cancer Drug Patent Case

Pfizer Fails to End Lawsuit Over Bextra, Celebrex Safety

U.S. Struggles with Pharmaceutical Goals in Asia Trade Talks

Big Pharma in Nervous Wait for India Verdict on Glivec Patent

Pfizer Gets Celebrex Patent Extension

Generics Brought Down Common Drug Prices in 2012

GlaxoSmithKline Unit Joins Patent Pool for AIDS Drugs

Obama Medicare Rebate Plan Could Hurt Drug Companies

Amgen Biosimilar Push Takes Aim at Blockbusters

Buyers Eye Multibillion Deal for Brazilian Drugmaker

Zoetis IPO Prices at $26; Largest US Deal Since Facebook

AbbVie Forecasts Slower Humira Growth

Pfizer Q4 Results Top Forecast

China to Cut Prices of More than 400 Drugs from February

Italy's Philogen Signs Drug License Deal with Pfizer

Entering the Age of the $1 Million Medicine

US FDA New Drug Approvals Hit 16-Year High in 2012

FDA Approves Bristol Myers, Pfizer's Anti-Clotting Drug Eliquis

Mitsubishi Chem to Buy Capsule Maker from Carlyle

Eli Lilly to Pay $29 Million to Settle US SEC Bribery Case

Drug Industry Treading Water on R&D Productivity

Ranbaxy Halts Generic Lipitor Production After Recall

Canada's Supreme Court Strips Viagra Patent from Pfizer

Pfizer Quarterly Revenue Fall Far Short of Forecasts

Nestle Names Cantarell Head of Nutrition Unit

US Foreign Bribery Penalties for Drugmakers May Lack Bite

GSK Raises Bet on AIDS Drug with New Shionogi Deal

Amgen Q3 Profits Up

68 more articles

Top-Feature

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Virtual Event

Digitalization in the Chemical Industry

CHEManager Spotlight

Digitalization in the Chemical Industry

29 April 2026 | This webinar explores how chemical industry organizations can design a digital‑ and AI‑ready operating model focused on clarity, usability, and measurable value.